Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

NCT00660374 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin NPH
DRUG: EX1000

Sponsor

Novo Nordisk A/S